| Heme oxygenase‐1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2, 3‐dioxygenase M Hill, V Pereira, C Chauveau, R Zagani, S Remy, L Tesson, D Mazal, ... The FASEB Journal 19 (14), 1957-1968, 2005 | 188 | 2005 |
| Inhibition of adipose triglyceride lipase (ATGL) by the putative tumor suppressor G0S2 or a small molecule inhibitor attenuates the growth of cancer cells R Zagani, W El-Assaad, I Gamache, JG Teodoro Oncotarget 6 (29), 28282, 2015 | 91 | 2015 |
| Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4a2—new therapeutic targets for colorectal cancers R Zagani, N Hamzaoui, W Cacheux, A De Reynies, B Terris, ... Gastroenterology 137 (4), 1358-1366. e3, 2009 | 58 | 2009 |
| GEF-H1 signaling upon microtubule destabilization is required for dendritic cell activation and specific anti-tumor responses AS Kashyap, L Fernandez-Rodriguez, Y Zhao, G Monaco, MP Trefny, ... Cell reports 28 (13), 3367-3380. e8, 2019 | 44 | 2019 |
| Bacterial peptidoglycan fragments differentially regulate innate immune signaling KL Bersch, KE DeMeester, R Zagani, S Chen, KA Wodzanowski, S Liu, ... ACS central science 7 (4), 688-696, 2021 | 39 | 2021 |
| Nitric oxide and indoleamine 2, 3-dioxygenase mediate CTLA4Ig-induced survival in heart allografts in rats M Hill, R Zagani, C Voisine, C Usal, I Anegon Transplantation 84 (8), 1060-1063, 2007 | 22 | 2007 |
| T cell fate following Salmonella infection is determined by a STING-IRF1 signaling axis in mice SM Park, T Omatsu, Y Zhao, N Yoshida, P Shah, R Zagani, HC Reinecker Communications Biology 2 (1), 464, 2019 | 16 | 2019 |
| Major role for CD8 T cells in the protection against Toxoplasma gondii following dendritic cell vaccination. DPI Guiton R1, Zagani R parasite immunology, 2009 | 16 | 2009 |
| Microbial recognition by GEF-H1 controls IKKε mediated activation of IRF5 Y Zhao, R Zagani, SM Park, N Yoshida, P Shah, HC Reinecker Nature communications 10 (1), 1349, 2019 | 13 | 2019 |
| Deletion of the putative tumor suppressor gene, G0s2, does not affect progression of Eμ-Myc driven lymphomas in mice R Zagani, I Gamache, JG Teodoro Leukemia research 40, 100-102, 2016 | 4 | 2016 |
| Role of prostaglandins in colorectal cancer R Zagani, N Hamzaoui, D Lamarque Hépato-Gastro & Oncologie Digestive 16 (2), 137-145, 2009 | | 2009 |
| Rôle des prostaglandines dans le cancer colorectal R Zagani, N Hamzaoui, D Lamarque Hépato-Gastro & Oncologie Digestive 16 (2), 137-145, 2009 | | 2009 |
| CD8+ but not CD4+ T cells are the major effectors of Toxoplasma gondii protective immunity induced by dendritic cell vaccination R Guiton, R Zagani, I Dimier-Poisson | | 2008 |
| Les inhibiteurs de la cyclo-oxygenase de type 2 reduisent l'expression de l'osteopontine intra-tumorale par l'intermediaire du recepteur nucleaire orphelin Nr4a2 R Zagani, N Hamzaoui, C Perret, S Chaussade, D Lamarque GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 32 (1), P149, 2008 | | 2008 |
| CTLA4Ig-induced transplantation tolerance: Not only IDO counts. M Hill, C Voisine, R Zagani, L Tesson, R Josien, I Anegon AMERICAN JOURNAL OF TRANSPLANTATION 4, 189-189, 2004 | | 2004 |
| The Federation of American Societies for Experimental Biology E Evangelou, TA Trikalinos, JPA Ioannidis, L Thon, H Mohlig, S Mathieu, ... | | |
| Major role for CD8 T cells in the protection against Toxoplasma gondii following dendritic cell vaccination. | | |
